About Foldax
Foldax is a company based in Salt Lake City (United States) founded in 2006 by Mory Gharib and Frank Maguire. Foldax has raised $43.74 million across 13 funding rounds from investors including Caltech, MemorialCare Innovation Fund and Kairos Ventures. The company has 1 employees as of April 08, 2024. Foldax offers products and services including TRIA Heart Valves and LifePolymer Material. Foldax operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Salt Lake City, United States
- Employees 1 as on 08 Apr, 2024
- Founders Mory Gharib, Frank Maguire
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Foldax India Private Limited
- Date of Incorporation 15 Sep, 2020
- Jurisdiction Goa, Goa, India
-
Annual Revenue
$52.62 K (USD)0as on Mar 31, 2021
-
Net Profit
$4.28 K (USD)0as on Mar 31, 2021
-
EBITDA
$7.01 K (USD)0as on Mar 31, 2021
-
Total Equity Funding
$43.74 M (USD)
in 13 rounds
-
Latest Funding Round
$7 M (USD), Series D
Oct 18, 2023
-
Investors
Caltech
& 3 more
-
Employee Count
1
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Foldax
Foldax offers a comprehensive portfolio of products and services, including TRIA Heart Valves and LifePolymer Material.
Polymer-based valves for surgical and transcatheter use in heart therapy.
Proprietary polymer for durable heart valve construction and applications.
People of Foldax
Unlock access to complete
Funding Insights of Foldax
Foldax has successfully raised a total of $43.74M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $7 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Foldax
Foldax has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Caltech, MemorialCare Innovation Fund and Kairos Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage life sciences & tech focused VC firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Locked | Locked | Locked | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Locked | Locked | Locked |
Investor details for Foldax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Foldax
Investment portfolio details for Foldax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Foldax
Detailed financials for Foldax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Foldax Comparisons
Peer comparison for Foldax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Foldax
Foldax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| Locked | Locked | Locked |
Smart medical devices for heart valve diseases are developed.
|
Detailed competitors of Foldax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Foldax
Complete news archive for Foldax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Foldax
Foldax was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Foldax is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Frank Maguire is the current CEO of Foldax. They have also founded this company.
Foldax is a funded company, having raised a total of $43.74M across 13 funding rounds to date.
As of Apr 08, 2024, the latest employee count at Foldax is 1.
Annual revenue of Foldax is $52.62K as on Mar 31, 2021.
Foldax was established in 2006 in Salt Lake City, United States, within the medical device sector. Bio-polymeric heart valves are created to address aortic, mitral, and tricuspid valve conditions. LifePolymer, a biopolymer material, is incorporated into transcatheter devices for these interventions. Operations center on research and development of durable valve replacements, targeting cardiovascular treatments in a regulated industry.
Foldax's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Foldax offers TRIA Heart Valves and LifePolymer Material.
Foldax has 4 investors. Key investors include Caltech, MemorialCare Innovation Fund, Kairos Ventures, and BioStar Capital.